The accessibility of Covid-19 vaccine toward commercialization using microneedles

Abstract

The abrupt development in December 2019 of a novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2) still harms the whole humankind and has damaged not just the medical system but the global economic and social balance. The World Health Organization soon named COVID-19 as a global pandemic. However, since its breakout we understand COVID-19 substantially and have tried or are presently in research numerous therapies and pharmacology treatments to reduce its risks. Infectious illness prevention is the most efficient technique. As novel immunization methods, microneedles have become more attractive. Based on its mechanism for action, painlessness and convenience of usage, microneedle is a very effective technique that delivers transdermal vaccines. The dissolving microneedle is important in achieving herd immunity and is advantageous for the population. Also, viable options for the fabrication of covid- 19 vaccine are solid microneedles, Hollow microneedles. Because of safety, effective stability, this platform has become very lucrative and user pleasant and at a commercial cost, and as a Covid-19 vaccine delivery system may play an increasingly important role.